Auremune

📍 Sweden💰 Last funded Apr 2013
Pharmaceuticals🌐 auremune.com
Website LinkedIn
Auremune aims to develop the world’s first preventive vaccine against atopic allergy, such as asthma, hay fever, eczema and food allergies.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
2
Frequently asked questions
Who invested in Auremune?
Auremune has 2 investors on record on gritt.io.
When did Auremune last raise funding?
The most recent investment in Auremune recorded on gritt.io was in April 2013.
What industry is Auremune in?
Auremune operates in Pharmaceuticals. Find similar Pharmaceuticals investors on gritt.io.
Where is Auremune based?
Auremune is headquartered in Sweden.